
Join to View Full Profile
800 Washington StBoston, MA 02111
Phone+1 617-636-5982
Are you Dr. Junghans?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Junghans, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Rhode Island. He is an Associate Professor at Boston University Sch of Med.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1983 - 1986
- University of Miami Leonard M. Miller School of MedicineClass of 1983
Certifications & Licensure
- MA State Medical License 1991 - 2026
- RI State Medical License 2004 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsBenign tumors in TSC are amenable to treatment by GD3 CAR T cells in miceAncy Thomas, Saurav Sumughan, Emilia R. Dellacecca, Rohan Shivde, Nicola Lancki
JCI Insight. 2021-11-22 - 46 citationsAntigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R. Dellacecca, Cormac Cosgrove, Rohan Shivde, Dinesh Jaishankar
Frontiers in Immunology. 2020-12-01 - 49 citationsHITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery.Steven C. Katz, Ashley E. Moody, Prajna Guha, John C. Hardaway, Ethan A. Prince
Journal for Immunotherapy of Cancer. 2020-08-01
Grant Support
- Advanced generation infection-proof anti-HIV CAR-T with YY1 RNAi to block T cell exhaustion in NHP modelIT BIO, LLC2020–2025